Pyridoclax

CAS No. 1651890-44-6

Pyridoclax ( MR-29072 )

Catalog No. M12523 CAS No. 1651890-44-6

Pyridoclax (MR29072) is a highly potent Mcl-1 inhibitor with Kd of 25 nM, disrupts Mcl-1/Bim interaction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pyridoclax
  • Note
    Research use only, not for human use.
  • Brief Description
    Pyridoclax (MR29072) is a highly potent Mcl-1 inhibitor with Kd of 25 nM, disrupts Mcl-1/Bim interaction.
  • Description
    Pyridoclax (MR29072) is a highly potent Mcl-1 inhibitor with Kd of 25 nM, disrupts Mcl-1/Bim interaction; strongly sensitizes ovarian cancer chemoresistant IGROV1-R10 cells to Bcl-xL targeting siRNA and ABT-737, leading to massive apoptosis, can not induce cell death as single agents; induces ER stress and modifies Bcl-2 family expression, but its cytotoxic effect does not require these events.
  • Synonyms
    MR-29072
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    Bcl-2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1651890-44-6
  • Formula Weight
    426.51
  • Molecular Formula
    C29H22N4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC1=CC(C2=NC=C(C3=CC=CN=C3)C=C2/C=C/C4=CC=CC=C4)=CN=C1C5=CC=CN=C5
  • Chemical Name
    (E)-3'-methyl-3''-styryl-3,2':5',2'':5'',3'''-quaterpyridine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gloaguen C, et al. J Med Chem. 2015 Feb 26;58(4):1644-68.
2. Groo AC, et al. Eur J Pharm Sci. 2017 Jan 15;97:218-226.
molnova catalog
related products
  • Obatoclax

    A potent inhibitor of Bcl-2 family with IC50s of 1-7 uM for Bcl-2, Bcl-XL, Bcl-w, Bcl-B, Mcl-1 and Bfl-1.

  • VU661013

    VU661013 (VU-661013) is a novel potent, selective MCL-1 inhibitor with Ki of 97 pM (human MCL-1) in TR-FRET assay.

  • S55746 hydrochloride

    S55746 (BCL201, Servier-1) is a novel potent, selective, orally bioavailable inhibitor of BCL-2 with Ki of 1.3 nM.